Vycor Medical (VYCO) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,133.00 |
| Dec 31, 2025 | 1,172.00 |
| Sep 30, 2025 | 4,892.00 |
| Jun 30, 2025 | 2,900.00 |
| Mar 31, 2025 | 1,843.00 |
| Dec 31, 2024 | -39.00 |
| Sep 30, 2024 | 154.00 |
| Jun 30, 2024 | 2,400.00 |
| Mar 31, 2024 | 751.00 |
| Dec 31, 2023 | -456.00 |
| Sep 30, 2023 | 452.00 |
| Jun 30, 2023 | 5,009.00 |
| Mar 31, 2023 | 5,539.00 |
| Dec 31, 2022 | 6,164.00 |
| Sep 30, 2022 | 2,118.00 |
| Jun 30, 2022 | -98.00 |
| Mar 31, 2022 | 4,822.00 |
| Dec 31, 2021 | 5,202.00 |
| Sep 30, 2021 | -1,741.00 |
| Jun 30, 2021 | 6,489.00 |
| Mar 31, 2021 | 3,466.00 |
| Dec 31, 2020 | 8,847.00 |
| Sep 30, 2020 | 7,812.00 |
| Jun 30, 2020 | 7,269.00 |
| Mar 31, 2020 | 13,197.00 |
| Sep 30, 2019 | 11,277.00 |
| Jun 30, 2019 | 22,120.00 |
| Mar 31, 2019 | 32,477.00 |
| Dec 31, 2018 | 5,214.00 |
| Sep 30, 2018 | 4,403.00 |
| Jun 30, 2018 | 7,941.00 |
| Mar 31, 2018 | 6,962.00 |
| Dec 31, 2017 | 3,868.00 |
| Sep 30, 2017 | 11,083.00 |
| Jun 30, 2017 | 11,968.00 |
| Mar 31, 2017 | 1,759.00 |
| Dec 31, 2016 | 12,234.00 |
| Sep 30, 2016 | 45,359.00 |
| Jun 30, 2016 | 54,238.00 |
| Mar 31, 2016 | 33,403.00 |
| Dec 31, 2015 | 25,502.00 |
| Sep 30, 2015 | 32,625.00 |